Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.110
-0.170 (-13.28%)
At close: Nov 16, 2026, 4:00 PM EST
1.140
+0.030 (2.70%)
After-hours: Nov 16, 2026, 7:58 PM EST

Cabaletta Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-193.64-172.24-125.14-74.66-54.14-46.31
Net Income
-189.51-167.86-115.86-67.68-52.98-46.29
Earnings Per Share
-1.37-2.10-2.34-1.65-1.81-1.80
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
299.38133.6163.96241.25106.55122.22
Total Debt
23.1727.115.65.025.14-
Net Cash (Debt)
276.21106.5148.36236.23101.41122.22
Net Cash Growth
105.89%-28.21%-37.20%132.95%-17.03%12.48%
Net Cash Per Share
1.991.333.005.773.464.75

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-162.16-131.08-88.22-53.55-46.38-34.11
Capital Expenditures
-0.35-1.23-2.21-0.69-2.45-1.17
Free Cash Flow
-162.51-132.31-90.43-54.24-48.83-35.28
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.